Xenetic Biosciences, Inc. SEC filings XBIO
Xenetic Biosciences, Inc. has 484 filings in SEC EDGAR's recent list, going back to Nov 21, 2011. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K/A | Amended annual report | Apr 24, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Oct 31, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | May 13, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Oct 31, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 26, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Nov 13, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Apr 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 22, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Apr 28, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 22, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Apr 28, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 16, 2021 | Dec 31, 2020 |
| 10-K/A | Amended annual report | Apr 29, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 26, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Apr 30, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 29, 2019 | Dec 31, 2018 |
| 10-K/A | Amended annual report | Apr 30, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 30, 2018 | Dec 31, 2017 |
| 10-K/A | Amended annual report | May 1, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 31, 2017 | Dec 31, 2016 |
| 10-K/A | Amended annual report | May 6, 2016 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Apr 29, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 30, 2016 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Jul 20, 2015 | Dec 31, 2013 |
| 10-K/A | Amended annual report | Apr 30, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Apr 15, 2015 | Dec 31, 2014 |
| 10-K/A | Amended annual report | Feb 18, 2015 | Dec 31, 2013 |
| 10-K/A | Amended annual report | Apr 30, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Apr 15, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Nov 27, 2013 | Aug 31, 2013 |
| 10-K | Annual report | Dec 14, 2012 | Aug 31, 2012 |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Framingham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534525
- Former names
- General Sales & Leasing, Inc. (until Jan 10, 2014); GENERAL AIRCRAFT INC. (until Feb 12, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.